These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 21761262)

  • 1. Rich stimulus sampling for between-subjects designs improves model selection.
    Young ME; Cole JJ; Sutherland SC
    Behav Res Methods; 2012 Mar; 44(1):176-88. PubMed ID: 21761262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of multinomial and binomial proportion methods for analysis of multinomial count data.
    Galyean ML; Wester DB
    J Anim Sci; 2010 Oct; 88(10):3452-63. PubMed ID: 20601524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parameter recovery and model selection in mixed Rasch models.
    Preinerstorfer D; Formann AK
    Br J Math Stat Psychol; 2012 May; 65(2):251-62. PubMed ID: 21675964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review on Monte Carlo simulation methods as they apply to mutation and selection as formulated in Wright-Fisher models of evolutionary genetics.
    Mode CJ; Gallop RJ
    Math Biosci; 2008 Feb; 211(2):205-25. PubMed ID: 18190932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian inference of risk ratio of two proportions using a double sampling scheme.
    Rahardja D; Young DM
    J Biopharm Stat; 2011 May; 21(3):393-404. PubMed ID: 21442515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simulation study to assess statistical methods for binary repeated measures data.
    Masaoud E; Stryhn H
    Prev Vet Med; 2010 Feb; 93(2-3):81-97. PubMed ID: 20004989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal sampling schedule of diet components: model robustness to departure from assumptions.
    St-Pierre NR; Cobanov B
    J Dairy Sci; 2007 Dec; 90(12):5395-404. PubMed ID: 18024730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monte Carlo probabilistic sensitivity analysis for patient level simulation models: efficient estimation of mean and variance using ANOVA.
    O'Hagan A; Stevenson M; Madan J
    Health Econ; 2007 Oct; 16(10):1009-23. PubMed ID: 17173339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient chain moves for Monte Carlo simulations of a wormlike DNA model: excluded volume, supercoils, site juxtapositions, knots, and comparisons with random-flight and lattice models.
    Liu Z; Chan HS
    J Chem Phys; 2008 Apr; 128(14):145104. PubMed ID: 18412482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Searching for convergence in phylogenetic Markov chain Monte Carlo.
    Beiko RG; Keith JM; Harlow TJ; Ragan MA
    Syst Biol; 2006 Aug; 55(4):553-65. PubMed ID: 16857650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian optimal designs for pharmacokinetic models: sensitivity to uncertainty.
    Dokoumetzidis A; Aarons L
    J Biopharm Stat; 2007; 17(5):851-67. PubMed ID: 17885870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Power equivalence in structural equation modelling.
    von Oertzen T
    Br J Math Stat Psychol; 2010 May; 63(Pt 2):257-72. PubMed ID: 19527562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptation of multiple logistic regression to a multiple inverse sampling design: application to the Isfahan healthy heart program.
    Salehi MM; Levy PS; Jamalzadeh MA; Chang KC
    Stat Med; 2006 Jan; 25(1):71-85. PubMed ID: 16217852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and analysis of in vitro antitumor pharmacodynamic studies.
    Kalns JE; Millenbaugh NJ; Wientjes MG; Au JL
    Cancer Res; 1995 Nov; 55(22):5315-22. PubMed ID: 7585594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Density guided importance sampling: application to a reduced model of protein folding.
    Thomas GL; Sessions RB; Parker MJ
    Bioinformatics; 2005 Jun; 21(12):2839-43. PubMed ID: 15802285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A statistical evaluation of toxicity study designs for the estimation of the benchmark dose in continuous endpoints.
    Slob W; Moerbeek M; Rauniomaa E; Piersma AH
    Toxicol Sci; 2005 Mar; 84(1):167-85. PubMed ID: 15483190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Choosing among techniques for quantifying single-case intervention effectiveness.
    Manolov R; Solanas A; Sierra V; Evans JJ
    Behav Ther; 2011 Sep; 42(3):533-45. PubMed ID: 21658534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parameter recovery for the rating scale model using PARSCALE.
    French GA; Dodd BG
    J Outcome Meas; 1999; 3(2):176-99. PubMed ID: 10204326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A robust approach for analyzing unbalanced factorial designs with fixed levels.
    Vallejo G; Ato M; Fernández MP
    Behav Res Methods; 2010 May; 42(2):607-17. PubMed ID: 20479192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal experimental design with the sigma point method.
    Schenkendorf R; Kremling A; Mangold M
    IET Syst Biol; 2009 Jan; 3(1):10-23. PubMed ID: 19154081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.